Calliditas Therapeutics stock jumps as kidney treatment gets FDA approval MarketWatch Dec 21, 2023 1:06pm
Travere Shares Rise 8.4%; Co. To Cut Staff, Focus on IgAN, HCU Treatments Global News Select Dec 4, 2023 9:59pm
Travere Therapeutics shares plunge as kidney-disease treatment has mixed results in trial MarketWatch Sep 21, 2023 12:01pm